• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科肺动脉高压的遗传学和基因组学。

Genetics and Genomics of Pediatric Pulmonary Arterial Hypertension.

机构信息

Department of Pediatrics, Irving Medical Center, Columbia University, 1150 St. Nicholas Avenue, New York, NY 10032, USA.

Department of Medicine, Irving Medical Center, Columbia University, 622 W 168th St, New York, NY 10032, USA.

出版信息

Genes (Basel). 2020 Oct 16;11(10):1213. doi: 10.3390/genes11101213.

DOI:10.3390/genes11101213
PMID:33081265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7603012/
Abstract

Pulmonary arterial hypertension (PAH) is a rare disease with high mortality despite recent therapeutic advances. The disease is caused by both genetic and environmental factors and likely gene-environment interactions. While PAH can manifest across the lifespan, pediatric-onset disease is particularly challenging because it is frequently associated with a more severe clinical course and comorbidities including lung/heart developmental anomalies. In light of these differences, it is perhaps not surprising that emerging data from genetic studies of pediatric-onset PAH indicate that the genetic basis is different than that of adults. There is a greater genetic burden in children, with rare genetic factors contributing to ~42% of pediatric-onset PAH compared to ~12.5% of adult-onset PAH. De novo variants are frequently associated with PAH in children and contribute to at least 15% of all pediatric cases. The standard of medical care for pediatric PAH patients is based on extrapolations from adult data. However, increased etiologic heterogeneity, poorer prognosis, and increased genetic burden for pediatric-onset PAH calls for a dedicated pediatric research agenda to improve molecular diagnosis and clinical management. A genomics-first approach will improve the understanding of pediatric PAH and how it is related to other rare pediatric genetic disorders.

摘要

肺动脉高压(PAH)是一种罕见疾病,尽管最近有了治疗进展,但死亡率仍然很高。这种疾病是由遗传和环境因素以及可能的基因-环境相互作用引起的。虽然 PAH 可以在整个生命周期中表现出来,但儿童发病的疾病尤其具有挑战性,因为它通常与更严重的临床过程和合并症有关,包括肺/心脏发育异常。鉴于这些差异,儿童发病 PAH 的遗传研究中出现的新数据表明,遗传基础与成人不同,这也许并不奇怪。儿童的遗传负担更大,罕见的遗传因素导致约 42%的儿童发病 PAH,而成人发病 PAH 约为 12.5%。新生变体在儿童中经常与 PAH 相关,至少占所有儿科病例的 15%。儿科 PAH 患者的医疗标准是基于对成人数据的推断。然而,儿童发病 PAH 的病因异质性增加、预后较差和遗传负担增加,需要制定专门的儿科研究议程,以改善分子诊断和临床管理。基于基因组学的方法将提高对儿科 PAH 的理解,以及它与其他罕见儿科遗传疾病的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e36/7603012/a7c25457ee20/genes-11-01213-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e36/7603012/62fda43eb456/genes-11-01213-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e36/7603012/50047af32f61/genes-11-01213-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e36/7603012/e5b5a0f99cea/genes-11-01213-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e36/7603012/a7c25457ee20/genes-11-01213-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e36/7603012/62fda43eb456/genes-11-01213-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e36/7603012/50047af32f61/genes-11-01213-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e36/7603012/e5b5a0f99cea/genes-11-01213-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e36/7603012/a7c25457ee20/genes-11-01213-g004.jpg

相似文献

1
Genetics and Genomics of Pediatric Pulmonary Arterial Hypertension.儿科肺动脉高压的遗传学和基因组学。
Genes (Basel). 2020 Oct 16;11(10):1213. doi: 10.3390/genes11101213.
2
Genetics and Other Omics in Pediatric Pulmonary Arterial Hypertension.儿童肺动脉高压中的遗传学与其他组学
Chest. 2020 May;157(5):1287-1295. doi: 10.1016/j.chest.2020.01.013. Epub 2020 Jan 30.
3
Genes that drive the pathobiology of pediatric pulmonary arterial hypertension.驱动小儿肺动脉高压病理生物学的基因。
Pediatr Pulmonol. 2021 Mar;56(3):614-620. doi: 10.1002/ppul.24637. Epub 2020 Jan 9.
4
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.国际肺动脉高压联盟对 4241 例肺动脉高压病例的罕见变异分析提示 FBLN2、PDGFD 和 PAH 中的罕见新生变异。
Genome Med. 2021 May 10;13(1):80. doi: 10.1186/s13073-021-00891-1.
5
Exome Sequencing in Children With Pulmonary Arterial Hypertension Demonstrates Differences Compared With Adults.对肺动脉高压患儿进行外显子组测序,结果显示与成人存在差异。
Circ Genom Precis Med. 2018 Apr;11(4):e001887. doi: 10.1161/CIRCGEN.117.001887.
6
Whole Exome Sequence Analysis Provides Novel Insights into the Genetic Framework of Childhood-Onset Pulmonary Arterial Hypertension.全外显子组测序为儿童期起病的肺动脉高压的遗传发病机制提供新的见解。
Genes (Basel). 2020 Nov 11;11(11):1328. doi: 10.3390/genes11111328.
7
The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension.小儿肺动脉高压的遗传流行病学。
J Pediatr. 2020 Oct;225:65-73.e5. doi: 10.1016/j.jpeds.2020.05.051. Epub 2020 Jun 2.
8
Clinical Implications of the Genetic Background in Pediatric Pulmonary Arterial Hypertension: Data from the Spanish REHIPED Registry.儿科肺动脉高压遗传背景的临床意义:来自西班牙 REHIPED 登记处的数据。
Int J Mol Sci. 2022 Sep 9;23(18):10433. doi: 10.3390/ijms231810433.
9
SOX17 Loss-of-Function Mutation Underlying Familial Pulmonary Arterial Hypertension.SOX17 功能丧失突变导致家族性肺动脉高压。
Int Heart J. 2021 May 29;62(3):566-574. doi: 10.1536/ihj.20-711. Epub 2021 May 1.
10
Genetics and genomics of pulmonary arterial hypertension.肺动脉高压的遗传学和基因组学。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D13-21. doi: 10.1016/j.jacc.2013.10.035.

引用本文的文献

1
Pulmonary hypertension in pediatrics: from clinical suspicion to management.小儿肺动脉高压:从临床怀疑到治疗
Eur J Pediatr. 2025 Apr 9;184(5):288. doi: 10.1007/s00431-025-06099-4.
2
Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series).肺血管疾病的精准医学:未来已来(2023年格罗弗会议系列)
Pulm Circ. 2025 Jan 2;15(1):e70027. doi: 10.1002/pul2.70027. eCollection 2025 Jan.
3
Embracing the challenges of neonatal and paediatric pulmonary hypertension.拥抱新生儿和儿科肺动脉高压的挑战。

本文引用的文献

1
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.国际肺动脉高压联盟对 4241 例肺动脉高压病例的罕见变异分析提示 FBLN2、PDGFD 和 PAH 中的罕见新生变异。
Genome Med. 2021 May 10;13(1):80. doi: 10.1186/s13073-021-00891-1.
2
Likely damaging de novo variants in congenital diaphragmatic hernia patients are associated with worse clinical outcomes.先天性膈疝患者中可能具有破坏性的新生变异与更差的临床结局相关。
Genet Med. 2020 Dec;22(12):2020-2028. doi: 10.1038/s41436-020-0908-0. Epub 2020 Jul 28.
3
The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension.
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01345-2024. Print 2024 Oct.
4
Early Pulmonary Hypertension in Preterm Infants.早产儿的早期肺动脉高压。
Clin Perinatol. 2024 Mar;51(1):171-193. doi: 10.1016/j.clp.2023.11.005. Epub 2023 Dec 16.
5
Diminished 100 Expression in a Newborn With Acinar Dysplasia and a Novel Variant: A Case Report.新生儿腺泡发育不良伴 100 表达减少及新型变异:病例报告。
Pediatr Dev Pathol. 2024 May-Jun;27(3):255-259. doi: 10.1177/10935266231213464. Epub 2023 Dec 3.
6
Hereditary pulmonary arterial hypertension burden in pediatrics: A single referral center experience.儿科遗传性肺动脉高压负担:一家转诊中心的经验
Front Pediatr. 2023 Mar 29;11:1050706. doi: 10.3389/fped.2023.1050706. eCollection 2023.
7
An intronic variant in TBX4 in a single family with variable and severe pulmonary manifestations.在一个患有多种严重肺部表现的单一家族中,TBX4基因的一个内含子变异。
NPJ Genom Med. 2023 Mar 6;8(1):7. doi: 10.1038/s41525-023-00350-3.
8
Molecular Function and Contribution of in Development and Disease.在发育和疾病中的分子功能和贡献。
Am J Respir Crit Care Med. 2023 Apr 1;207(7):855-864. doi: 10.1164/rccm.202206-1039TR.
9
Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH.肺动脉高压的遗传咨询和检测:国际肺动脉高压遗传研究联盟的共识声明。
Eur Respir J. 2023 Feb 23;61(2). doi: 10.1183/13993003.01471-2022. Print 2023 Feb.
10
A rare homozygous missense GDF2 (BMP9) mutation causing PAH in siblings: Does BMP10 status contribute?一种导致肺动脉高压的 GDF2(BMP9)罕见纯合错义突变:BMP10 状态是否有影响?
Am J Med Genet A. 2023 Jan;191(1):228-233. doi: 10.1002/ajmg.a.62996. Epub 2022 Oct 19.
小儿肺动脉高压的遗传流行病学。
J Pediatr. 2020 Oct;225:65-73.e5. doi: 10.1016/j.jpeds.2020.05.051. Epub 2020 Jun 2.
4
The mutational constraint spectrum quantified from variation in 141,456 humans.从 141456 名人类个体的变异中量化的突变约束谱。
Nature. 2020 May;581(7809):434-443. doi: 10.1038/s41586-020-2308-7. Epub 2020 May 27.
5
TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form.TBX4综合征:一种以最严重形式的肺动脉高压为突出表现的全身性疾病。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00585-2020. Print 2020 May.
6
Remodeling of active endothelial enhancers is associated with aberrant gene-regulatory networks in pulmonary arterial hypertension.活性内皮增强子的重塑与肺动脉高压中异常的基因调控网络有关。
Nat Commun. 2020 Apr 3;11(1):1673. doi: 10.1038/s41467-020-15463-x.
7
The application of 'omics' to pulmonary arterial hypertension.“组学”在肺动脉高压中的应用。
Br J Pharmacol. 2021 Jan;178(1):108-120. doi: 10.1111/bph.15056. Epub 2020 Apr 28.
8
Phenotype and outcome of pulmonary arterial hypertension patients carrying a mutation.携带突变的肺动脉高压患者的表型和结局。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.02340-2019. Print 2020 May.
9
Genotypes and Phenotypes of Chinese Pediatric Patients With Idiopathic and Heritable Pulmonary Arterial Hypertension-A Single-Center Study.中国儿童特发性和遗传性肺动脉高压患者的基因型和表型:一项单中心研究。
Can J Cardiol. 2019 Dec;35(12):1851-1856. doi: 10.1016/j.cjca.2019.07.628. Epub 2019 Aug 1.
10
Risk Assessment and Monitoring of Chronic Pulmonary Hypertension in Premature Infants.早产儿慢性肺动脉高压的风险评估与监测
J Pediatr. 2020 Feb;217:199-209.e4. doi: 10.1016/j.jpeds.2019.10.034. Epub 2019 Nov 14.